Noema Pharma raised $147 Million in a Series B financing round led by EQT Life Sciences to support its Phase 2 trials for CNS disorders.
Amount Raised
$147 Million
Round Type
Series B
BaselBiotechnologyHealth CareTherapeuticsInvestors
Description
Noema Pharma successfully closed a Series B extension financing round with an investment from EQT Life Sciences, bringing the total capital raised to approximately $147 million. This financing will support Noema Pharma’s four active Phase 2 trials, with key data readouts anticipated in 2025.
Quick answer
Noema Pharma raised $147 Million in a Series B round, dated December 11, 2024. Investors: Forbion, Jeito Capital, Sofinnova Partners, Gilde Healthcare, Polaris Partners, Invus, UPMC Enterprises and EQT Life Sciences. Noema Pharma is based in Basel, Basel City, Switzerland.
- How much did Noema Pharma raise?
- Noema Pharma raised $147 Million in a Series B round on December 11, 2024.
- Who invested in Noema Pharma?
- Forbion, Jeito Capital, Sofinnova Partners, Gilde Healthcare, Polaris Partners, Invus, UPMC Enterprises and EQT Life Sciences are named as investors in this round.
- What does Noema Pharma do?
- Noema Pharma is a clinical-stage biotech company advancing a portfolio of transformative, first-in-disease therapeutics targeting neuroscience-based conditions with high unmet need.
- Where is Noema Pharma based and how big is it?
- Noema Pharma is based in Basel, Basel City, Switzerland. Fundz records about 32 employees.
- Who are the decision-makers at Noema Pharma?
- Fundz holds 2 contacts at Noema Pharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Noema Pharma that raised within 45 days of this round, from Fundz verified event records.
- Dermata Therapeutics raised $2.5M (Seed) on January 21, 2025.
- Phio Pharmaceuticals raised $153K (Seed) on January 17, 2025.
- VisiRose raised $3M (Seed) on January 16, 2025.
- Phio Pharmaceuticals raised $208K (Seed) on January 15, 2025.
- Phio Pharmaceuticals raised $266K (Seed) on January 14, 2025.
- First Ascent Biomedical raised $6M (Angel) on January 13, 2025.
Who to call at Noema Pharma, and when
A new round usually means Noema Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Noema Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Noema Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Noema Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Noema Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNoema Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.